A Phase I Study of Weekly R1507, A Human Monoclonal Antibody Insulin-like Growth Factor-I Receptor Antagonist, in Patients with Advanced Solid Tumors

R. Kurzrock, A. Patnaik, J. Aisner, T. Warren, S. Leong, R. Benjamin, S. G. Eckhardt, J. E. Eid, G. Greig, K. Habben, C. D. McCarthy, L. Gore
2010 Clinical Cancer Research  
doi:10.1158/1078-0432.ccr-09-3220 pmid:20371689 fatcat:pvlszef4hjdf7hbfwxfeavbjxi